Patents by Inventor Sebastian BELMAR

Sebastian BELMAR has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ATF6 INHIBITORS AND USES THEREOF
    Publication number: 20240124434
    Abstract: Compounds as inhibitors of Activating Transcription Factor 6 (ATF6) are provided. The compounds may find use as therapeutic agents for the treatment of diseases or disorders mediated by ATF6 and may find particular use in the treatment of viral infections, neurodegenerative diseases, vascular diseases, or cancer.
    Type: Application
    Filed: May 26, 2023
    Publication date: April 18, 2024
    Inventors: Jennifer ALFARO, Sebastian BELMAR, Gonzalo Esteban NÚÑEZ VASQUEZ, Brahmam PUJALA, Balaji Dashrath SATHE, Pooja THAKRAL, Rajesh Kumar PATIDAR, Sebastian BERNALES, Sarvajit CHAKRAVARTY
  • Inhibitors of fibroblast activation protein
    Patent number: 11780821
    Abstract: Compounds and compositions for modulating fibroblast activation protein (FAP) are described. The compounds and compositions may find use as therapeutic agents for the treatment of diseases, including hyperproliferative diseases.
    Type: Grant
    Filed: December 14, 2018
    Date of Patent: October 10, 2023
    Assignee: PRAXIS BIOTECH LLC
    Inventors: Jennifer Alfaro, Sebastian Belmar, Sebastian Bernales, Brahmam Pujala, Dayanand Panpatil, Bhawana Bhatt
  • INHIBITORS OF FIBROBLAST ACTIVATION PROTEIN
    Publication number: 20230144841
    Abstract: Compounds and compositions for modulating fibroblast activation protein (FAP) are described. The compounds and compositions may find use as therapeutic agents for the treatment of diseases, including hyperproliferative diseases.
    Type: Application
    Filed: September 14, 2022
    Publication date: May 11, 2023
    Inventors: Brahmam PUJALA, Dayanand PANPATIL, Sebastian BERNALES, Sebastian BELMAR, Gonzalo Andrés URETA DÍAZ
  • ATF6 MODULATORS AND USES THEREOF
    Publication number: 20230028584
    Abstract: Compounds (1-2) as modulators of Activating Transcription Factor 6 (ATF6) are provided. The compounds may find use as therapeutic agents for the treatment of diseases or disorders mediated by ATF6 and may find particular use in the treatment of viral infections, neurodegenerative diseases, vascular diseases, or cancer.
    Type: Application
    Filed: October 9, 2020
    Publication date: January 26, 2023
    Inventors: Brahmam PUJALA, Balaji Dashrath SATHE, Sebastian BERNALES, Gonzalo Andrés URETA DÍAZ, Sebastian BELMAR
  • ATF6 MODULATORS AND USES THEREOF
    Publication number: 20220389001
    Abstract: Compounds (I) as modulators of Activating Transcription Factor 6 (ATF6) are provided. The compounds may find use as therapeutic agents for the treatment of diseases or disorders mediated by ATF6 and may find particular use in the treatment of viral infections, neurodegenerative diseases, vascular diseases, or cancer.
    Type: Application
    Filed: October 9, 2020
    Publication date: December 8, 2022
    Inventors: Brahmam PUJALA, Balaji Dashrath SATHE, Pooja THAKRAL, Sebastian BERNALES, Gonzalo Andrés URETA DÍAZ, Sebastian BELMAR
  • Inhibitors of fibroblast activation protein
    Patent number: 11504364
    Abstract: Compounds and compositions for modulating fibroblast activation protein (FAP) are described. The compounds and compositions may find use as therapeutic agents for the treatment of diseases, including hyperproliferative diseases.
    Type: Grant
    Filed: December 21, 2019
    Date of Patent: November 22, 2022
    Assignee: PRAXIS BIOTECH LLC
    Inventors: Brahmam Pujala, Dayanand Panpatil, Sebastian Bernales, Sebastian Belmar, Gonzalo Andrés Ureta Díaz
  • INHIBITORS OF ARGINASE
    Publication number: 20220017541
    Abstract: Compounds and compositions as inhibitors of arginase are provided. They may find use as therapeutic agents for the treatment of diseases or conditions associated with expression or activity of arginase.
    Type: Application
    Filed: November 21, 2019
    Publication date: January 20, 2022
    Inventors: Sebastian BELMAR, Jennifer ALFARO, Gonzalo Esteban NÚÑEZ VASQUEZ, Sebastian BERNALES, Brahmam PUJALA, Dayanand PANPATIL, Pasha KHAN, Sarvajit CHAKRAVARTY, Gonzalo Andrés URETA DÍAZ
  • ATF6 INHIBITORS AND USES THEREOF
    Publication number: 20210221803
    Abstract: Compounds as inhibitors of Activating Transcription Factor 6 (ATF6) are provided. The compounds may find use as therapeutic agents for the treatment of diseases or disorders mediated by ATF6 and may find particular use in the treatment of viral infections, neurodegenerative diseases, vascular diseases, or cancer.
    Type: Application
    Filed: August 12, 2020
    Publication date: July 22, 2021
    Inventors: Jennifer ALFARO, Sebastian BELMAR, Gonzalo Esteban NÚÑEZ VASQUEZ, Brahmam PUJALA, Balaji Dashrath SATHE, Pooja THAKRAL, Rajesh Kumar PATIDAR, Sebastian BERNALES, Sarvajit CHAKRAVARTY
  • ATF6 inhibitors and uses thereof
    Patent number: 10829485
    Abstract: Compounds as inhibitors of Activating Transcription Factor 6 (ATF6) are provided. The compounds may find use as therapeutic agents for the treatment of diseases or disorders mediated by ATF6 and may find particular use in the treatment of viral infections, neurodegenerative diseases, vascular diseases, or cancer.
    Type: Grant
    Filed: April 6, 2019
    Date of Patent: November 10, 2020
    Assignee: BLACK BELT TX LTD
    Inventors: Jennifer Alfaro, Sebastian Belmar, Gonzalo Esteban Núñez Vasquez, Brahmam Pujala, Balaji Dashrath Sathe, Pooja Thakral, Rajesh Kumar Patidar, Sebastian Bernales, Sarvajit Chakravarty
  • INHIBITORS OF FIBROBLAST ACTIVATION PROTEIN
    Publication number: 20200216417
    Abstract: Compounds and compositions for modulating fibroblast activation protein (FAP) are described. The compounds and compositions may find use as therapeutic agents for the treatment of diseases, including hyperproliferative diseases.
    Type: Application
    Filed: January 3, 2020
    Publication date: July 9, 2020
    Inventors: Sebastian BERNALES, Brahmam PUJALA, Dayanand PANPATIL, Gonzalo Andrés URETA DÍAZ, Sebastian BELMAR
  • INHIBITORS OF FIBROBLAST ACTIVATION PROTEIN
    Publication number: 20200206216
    Abstract: Compounds and compositions for modulating fibroblast activation protein (FAP) are described. The compounds and compositions may find use as therapeutic agents for the treatment of diseases, including hyperproliferative diseases.
    Type: Application
    Filed: December 21, 2019
    Publication date: July 2, 2020
    Inventors: Brahmam Pujala, Dayanand Panpatil, Sebastian Bernales, Sebastian Belmar, Gonzalo Andrés Ureta Díaz
  • ATF6 INHIBITORS AND USES THEREOF
    Publication number: 20190367497
    Abstract: Compounds as inhibitors of Activating Transcription Factor 6 (ATF6) are provided. The compounds may find use as therapeutic agents for the treatment of diseases or disorders mediated by ATF6 and may find particular use in the treatment of viral infections, neurodegenerative diseases, vascular diseases, or cancer.
    Type: Application
    Filed: April 6, 2019
    Publication date: December 5, 2019
    Inventors: Jennifer ALFARO, Sebastian BELMAR, Gonzalo Esteban NÚÑEZ VASQUEZ, Brahmam PUJALA, Balaji Dashrath SATHE, Pooja THAKRAL, Rajesh Kumar PATIDAR, Sebastian BERNALES, Sarvajit CHAKRAVARTY
  • INHIBITORS OF FIBROBLAST ACTIVATION PROTEIN
    Publication number: 20190185451
    Abstract: Compounds and compositions for modulating fibroblast activation protein (FAP) are described. The compounds and compositions may find use as therapeutic agents for the treatment of diseases, including hyperproliferative diseases.
    Type: Application
    Filed: December 14, 2018
    Publication date: June 20, 2019
    Inventors: Jennifer ALFARO, Sebastian BELMAR, Sebastian BERNALES, Brahmam PUJALA, Dayanand PANPATIL, Bhawana BHATT